Mosanna Therapeutics
PrivateLast Round
Series A
Jun 9, 2025
Total Funding Raised
$80M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mosanna Therapeutics operates in Healthcare & Life Sciences and is based in Redwood City, California. Its latest recorded funding round was a Series A round in June 2025.
Mosanna Therapeutics is a biotechnology company that develops pharmaceutical therapeutics designed to treat obstructive sleep apnea through non-mechanical approaches.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mosanna Therapeutics Comparables
Compare Mosanna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apnimed | 89% | |
| Incannex Healthcare Inc. | 76% | |
| Shionogi & Co. | 68% |
For institutional investors. Book with your work email.
Mosanna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 9, 2025 | ||||
| Seed | Jul 13, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mosanna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A |
| Forbion | Series A |
| Forty51 Ventures | Series A, Seed |
| Norwest Venture Partners | Series A |
| Pivotal bioVenture Partners | Series A |
| Pivotal bioVenture Partners | Series A |
| Supermoon Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 63% MoM, reaching 2.1K.
- Jul 25, 2026
Monthly visitors grew 802% MoM, from 141 to 1.3K.
For institutional investors. Book with your work email.
Mosanna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mosanna Therapeutics's valuation, stock price, and market status.
Is Mosanna Therapeutics a public or private company?
Mosanna Therapeutics is a private company.
What is the current stock price of Mosanna Therapeutics?
Mosanna Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mosanna Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mosanna Therapeutics worth (valuation)?
Valuation information for Mosanna Therapeutics is not publicly available.
Can I buy Mosanna Therapeutics stock?
Mosanna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mosanna Therapeutics's last funding round?
Mosanna Therapeutics's most recent funding round was Series A on June 9, 2025.
Who are the main investors in Mosanna Therapeutics?
Key investors in Mosanna Therapeutics include EQT Life Sciences, Forty51 Ventures, Norwest Venture Partners, Pivotal bioVenture Partners, Pivotal bioVenture Partners.
Will Mosanna Therapeutics IPO soon?
No public IPO plans have been announced for Mosanna Therapeutics.
How can I track Mosanna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mosanna Therapeutics's shares on secondary markets.